Fulgent Genetics Income Tax Expense Over Time
| FLGT Stock | USD 18.30 0.23 1.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Fulgent Genetics Performance and Fulgent Genetics Correlation. Fulgent |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.52) | Revenue Per Share 9.255 | Quarterly Revenue Growth (0.15) | Return On Assets (0.04) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Tax Expense Analysis
Compare Fulgent Genetics and related stocks such as Quest Diagnostics, Waters, and Universal Health Services Income Tax Expense Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DGX | (50.2 M) | 349 M | 401.9 M | 500 M | 262 M | 373 M | 429 M | 241 M | 182 M | 247 M | 460 M | 597 M | 264 M | (248 M) | (235.6 M) |
| WAT | 3.1 M | 76.3 M | 26.2 M | 40.1 M | 59.1 M | 72.9 M | 78.6 M | 620.8 M | 88.4 M | 86 M | 89.3 M | 113.3 M | 130.1 M | 94 M | 85.7 M |
| UHS | 21.8 M | 247.5 M | 274.6 M | 315.3 M | 324.7 M | 395.2 M | 409.2 M | 363.7 M | 236.6 M | 238.8 M | 299.3 M | 305.7 M | 209.3 M | 221.1 M | 150.7 M |
| HOLX | 300 K | 12 M | (20.1 M) | 30.8 M | 45.6 M | 84.5 M | 475 M | (307.3 M) | (55.1 M) | (108.6 M) | 491.4 M | 286.2 M | 220.1 M | 75.6 M | 48.9 M |
Fulgent Genetics and related stocks such as Quest Diagnostics, Waters, and Universal Health Services Income Tax Expense description
My Equities
My Current Equities and Potential Positions
| Fulgent Genetics | FLGT |
| Classification | Healthcare |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 18.3
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.